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Background. Rapid diagnostic tests (RDTs) account for more than two-thirds of malaria diagnoses in Africa. Deletions of the 
Plasmodium falciparum hrp2 (pfhrp2) gene cause false-negative RDT results and have never been investigated on a national level. 
Spread of pfhrp2-deleted P.  falciparum mutants, resistant to detection by HRP2-based RDTs, would represent a serious threat to 
malaria elimination efforts.
Methods. Using a nationally representative cross-sectional study of 7,137 children under five years of age from the Democratic 
Republic of Congo (DRC), we tested 783 subjects with RDT-/PCR+ results using PCR assays to detect and confirm deletions of the 
pfhrp2 gene. Spatial and population genetic analyses were employed to examine the distribution and evolution of these parasites.
Results. We identified 149 pfhrp2-deleted parasites, representing 6.4% of all P. falciparum infections country-wide (95% con-
fidence interval 5.1–8.0%). Bayesian spatial analyses identified statistically significant clustering of pfhrp2 deletions near Kinshasa 
and Kivu. Population genetic analysis revealed significant genetic differentiation between wild-type and pfhrp2-deleted parasite 
populations (GST = .046, p ≤ .00001).
Conclusions. Pfhrp2-deleted P.  falciparum is a common cause of RDT-/PCR+ malaria among asymptomatic children in the 
DRC and appears to be clustered within select communities. Surveillance for these deletions is needed, and alternatives to HRP2-
specific RDTs may be necessary.
Keywords.  rapid diagnostic tests; false-negative; diagnostic resistance; histidine-rich protein 2; pfhrp3; hrp2; hrp3; RDT; dele-
tion; malaria.
BACKGROUND
Malaria-related mortality has fallen by 60% in Africa since 2000 
[1]. One of the cornerstones of malaria control programs is the 
use of RDTs instead of traditional microscopy for diagnosis. From 
2008 to 2014, annual sales of RDTs increased from 46 million to 
314 million units, representing a $151 million annual investment 
funded largely by multilateral and bilateral donors [2]. In 2014, 
RDTs accounted for 71% of all diagnostic testing employed to 
evaluate suspected malaria cases in Africa [1]. In the Democratic 
Republic of the Congo (DRC) and throughout Africa, RDTs have 
become the primary mode of malaria diagnosis.
Most widely used RDTs rely on the detection of histidine-rich 
protein 2 (HRP2), an antigen specific to Plasmodium falciparum. 
HRP2-based RDTs are known to generate false-positive results in 
the setting of persistent circulating HRP2 antigen after antima-
larial treatment and false-negative results in individuals with low 
levels of parasitemia beneath the assay’s threshold for detection, 
typically around 200 parasites/µL for most commercially avail-
able RDTs [2–4]. Recently, however, false-negative results have 
been reported in individuals infected with P. falciparum parasites 
harboring a deletion of the pfhrp2 gene [5–15]. Several of these 
reports also identified co-existing deletions of the P. falciparum 
histidine-rich protein 3 (pfhrp3) gene, which produces an antigen 
that exhibits some cross-reactivity with select HRP2-based RDTs. 
Understanding the distribution and evolution of these mutant 
parasites is a priority for the World Health Organization, which 
recently hosted a Technical Consultation on P. falciparum hrp2/3 
gene deletions and drafted interim guidance for investigating 
false-negative RDTs [16, 17]. It is unknown whether reliance on 
HRP2-based RDTs to guide treatment is exerting evolutionary 
pressure favoring the spread of this mutation.
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Such a finding could have significant implications for malaria 
control and elimination efforts in Africa. To date, pfhrp2-de-
leted mutant parasites have not been investigated using coun-
try-wide population-based surveys. Here, we use samples 
from a large, nationally representative cross-sectional study of 
children younger than 5 years of age in the DRC to determine 




Samples were collected from children under 5 years of age as 
part of the 2013–2014 DRC Demographic and Health Survey 
(DHS) [18]. The majority of children were asymptomatic at 
the time of sample collection. As previously described, heel- 
or finger-prick blood from each participant was analyzed by 
light microscopy for parasites, applied to an RDT targeting 
the P.  falciparum HRP2 antigen (SD BIOLINE Malaria Ag 
P.f., Standard Diagnostics, Gyeonggi-do, Republic of Korea),
and used to prepare dried blood spots (DBS) [18, 19]. The
SD BIOLINE Malaria Ag P.f. RDT is P.  falciparum-specific
and meets current procurement criteria recommended by
the World Health Organization, with high panel detection
scores of 95 and 99 (on a 100-point scale) at 200 and 2,000
parasites/µL, respectively [2]. Three diagnostic methods were
performed for each child: RDT, microscopy, and polymerase
chain reaction (PCR). After extracting DNA from the DBS
using established methods [20], a real-time PCR assay with a
limit of detection of 100 parasites/µL was employed to iden-
tify P. falciparum infection by amplifying a region of the sin-
gle-copy pfldh gene as previously described [19]. This study
was approved by the University of Kinshasa School of Public
Health and the University of North Carolina Institutional
Review Boards. Informed consent was obtained from a parent
or responsible adult for all subjects.
Detection of pfhrp2 Deletions
We performed PCR to identify the presence or absence of 
pfhrp2 deletions among the subset of P.  falciparum parasites 
with RDT-/PCR+ results. We included both microscopy-pos-
itive and -negative samples because excluding samples with 
insufficient parasite density for microscopic diagnosis could 
lead to an underestimate of the true pfhrp2-deleted parasite 
prevalence. We employed PCR assays targeting pfhrp2 exon 1 
and exon 2, using both 72°C and 60°C elongation temperatures 
based on reports of improved PCR sensitivity for AT-rich tar-
gets using lower elongation temperatures [21]. Additionally, 
we tested RDT+/PCR+ samples from select provinces to eval-
uate the occurrence of RDT-positivity due to HRP3 alone 
(expressed by pfhrp2-deleted parasites with an intact pfhrp3 
gene). PCR methods are described in the Supplementary 
Material.
Confirmation of P. falciparum Infection
For the subset of samples in which PCR assays failed to amplify 
either region of the pfhrp2 gene, we performed additional PCR 
assays targeting other single-copy genes to confirm that sufficient 
P. falciparum DNA persisted in each sample for amplification,
including the pfhrp3 gene as described below and/or the P. fal-
ciparum beta tubulin (Pf β-tubulin) gene (see Supplementary
Materials). Samples with successful amplification of pfhrp3 or Pf
β-tubulin were deemed to contain pfhrp2-deleted P. falciparum.
The presence of amplifiable DNA was further confirmed for a
subset of samples using PCR assays for multiple flanking micro-
satellite loci as described below.
Detection of Coexisting pfhrp3 Deletions
We performed PCR assays to detect co-existing complete pfhrp3 
deletions among pfhrp2-deleted P.  falciparum parasites. We 
employed assays targeting pfhrp3 exon 2, followed by assays for 
exon 1 as described in the Supplementary Material. Samples 
with negative results for these assays were deemed to contain 
coexisting pfhrp2 and pfhrp3 deletions.
Prevalence and Geographical Distribution of pfhrp2-Deleted P. falciparum
We calculated the prevalence of P. falciparum infections among 
children younger than 5 years of age, using PCR-positive infec-
tions (determined previously by the initial real-time PCR 
assay targeting pfldh) as the numerator and the total number 
tested as the denominator. We calculated the proportion of 
pfhrp2-deleted P.  falciparum infections overall and by prov-
ince, using pfhrp2 deletions as the numerator and total PCR-
positive P. falciparum cases as the denominator. All calculations 
utilized sample weights generated by the DHS to account for 
complex sampling design. Locations of pfhrp2-deleted isolates 
were mapped using R software (R Core Team, Vienna, Austria) 
and assessed for clustering by province using a Bayesian clus-
tering technique as previously described [22]. We allowed for 
20% of the study population to be included in the scanning 
window, consistent with other scan-based cluster methods. For 
the prior distributions for the null and non-null configurations, 
we specified conjugate gamma priors, such that null relative 
risks ranged between 0.95 and 1.05, and non-null relative risks 
ranged between 0 and 4 with 95% probability. Finally, we spec-
ified a prior probability of no clusters as 0.95 (consistent with a 
null hypothesis of no clustering). See Supplementary Material 
for details.
Microsatellite Analysis
In order to explore whether evolutionary selective pres-
sure favoring pfhrp2-deleted parasites was present (e.g. 
selective treatment based on HRP2-based RDT results), 
we performed additional testing on a subset of pfhrp2-de-
leted parasites. We chose to test all pfhrp2-deleted para-
sites identified in Kinshasa, North Kivu, and South Kivu 
Provinces. Additionally, an equal number of randomly 
selected, geographically matched HRP2-positive control 
samples were included in our testing to achieve a 1:1 ratio 
of deleted to control samples in each province, resulting 
in a frequency-matched sample that was analyzed without 
regard to individually matched pairs. We performed PCR 
to amplify six previously described microsatellite regions 
flanking the pfhrp2 gene and employed capillary electropho-
resis (Eton Biosciences, San Diego, CA) to analyze the ampl-
icons [6]. Primers and reaction conditions are described 
in Supplementary Table  1. Capillary electrophoresis chro-
matograms were visualized and scored for amplicon length 
using GeneMapper v.  4.1 (Applied Biosystems, Foster City, 
CA). We considered peaks with an intensity of less than 200 
relative fluorescent units (RFU) as background signal and 
analyzed only the dominant peak at each locus. We adjusted 
amplicon lengths according to the difference between P. fal-
ciparum 3D7 controls and their theoretical fragment lengths 
from the consensus 3D7 (v3) sequence in PlasmoDB [23].
The adjusted amplicon lengths were then used to cre-
ate haplotypes for each sample consisting of each of the six 
microsatellite loci. We defined haplotypes in the form of 
repeats per microsatellite locus rather than fragment lengths. 
We calculated the number of repeats in each amplicon by 
dividing the difference between our adjusted amplicon length 
and the minimum theoretical amplicon length, assuming 
zero repeats, by the repeat unit length. Only the dominant 
haplotype for each sample was included in population genetic 
analyses.
Table 1. Characteristics of Children Infected With P. falciparum
Characteristic All subjects All P. falciparum infections* pfhrp2-deleted P. falciparum p**
N (weighted prevalence [95% CI]) 7,137 2752 (34.8 [32.3 – 37.4]) 149 (6.4 [5.1 – 8.0]) —
Age in months, median (IQR) 32 (19 – 46) 36 (23 – 48) 31 (14 – 45) 0.0007
Female sex, n (weighted proportion) 3568 (49.9) 1340 (49.0) 67 (48.4) 0.92
Microscopy positive, n (weighted proportion) -- 1695 (58.7) 18 (9.7) <0.0001
Fever in last 2 weeks, n (weighted proportion)& 2094 (0.32) 934 (39.8) 27 (18.5) 0.0004
Province, n (weighted prevalence [95% CI])
Kinshasa 362 92 (25.6 [19.9,32.1])  20 (21.9 [13.9,32.8]) +
Kwango 308 67 (19.4 [13.3,27.4]) 9 (12.8 [5.4,27.4]) --
Kwilu 360 70 (18.9 [14.0,24.9]) 6 (3.0 [1.1,8.2]) --
Mai-Ndombe 272 116 (44.0 [31.9,56.8]) 4 (9.6 [2.6,29.6]) --
Kongo Central 321 148 (43.1 [31.6,55.4]) 6 (4.2 [1.5,11.7]) --
Equateur 198 57 (23.6 [11.4,42.5]) 3 (2.8 [0.4,18.7]) --
Mongala 255 74 (36.6 [28.3,45.7]) 5 (4.4 [0.9,19.0]) --
Nord-Ubangi 231 143 (61.5 [46.6,74.6]) 5 (5.3[1.7,15.9]) --
Sud-Ubangi 276 86 (29.5 [23.6,36.2]) 7 (12.4 [5.4,26.1]) --
Tshuapa 205 56 (26.3 [16.4,39.5]) 5 (8.1 [2.7,22.1]) --
Kasai 310 118 (34.5 [20.9,51.2]) 2 (1.3 [0.3,5.1]) --
Kasai-Central 327 155 (50.9 [42.1,59.7]) 3 (3.4 [1.2,9.2]) --
Kasai-Oriental 255 106 (36.4 [22.8,52.6]) 3 (3.2 [0.9,11.1]) --
Lomami 351 221 (63.6 [52.7,73.3]) 5 (1.8 [0.5,5.9]) --
Sankuru 194 68 (26.4 [12.2,48.0]) 6 (14.8 [5.6,33.8]) --
Haut-Katanga 236 81 (31.7 [19.1,47.8]) 3 (3.5 [1.1,10.5]) --
Haut-Lomami 261 99 (42.8 [34.0,52.2]) 3 (3.7 [1.0,12.5]) --
Lualaba 176 87 (44.9 [30.8,59.9]) 2 (5.7 [1.1,25.5]) --
Tanganyka 245 157 (61.7 [45.1,75.9]) 3 (1.7 [0.3,9.5]) --
Maniema 349 182 (50.6 [38.0,63.1]) 13 (4.6 [2.1,10.0]) --
Nord-Kivu 426 72 (12.2 [8.5,17.3]) 12 (15.5 [7.5,29.4]) +
Bas-Uele 180 109 (68.2 [54.9,79.1]) 1 (0.2[0,1.8]) --
Haut-Uele 170 87 (57.5 [46.6,67.7]) 0 (0[NA]) --
Ituri 255 122 (43.7 [30.6,57.8]) 9 (11.5 [6.4,19.7]) +
Tshopo 225 106 (45.3 [36.3,54.6]) 6 (4.5 [1.5,12.3]) --
Sud-Kivu 389 73 (14.2 [9.8,20.0]) 8 (18.3 [7.1,39.9]) +
* Diagnosed by real-time PCR targeting the pfldh gene during initial screening, as previously described [19].
** Comparing pfhrp2-deleted to non-deleted P. falciparum.
&Fever in the last 2 weeks based on survey response.
+Provinces with geographical clustering of pfhrp2-deleted P. falciparum by Bayesian spatial cluster analysis.
Abbreviations: CI, confidence interval; IQR, interquartile range; NA, not applicable.
Population Genetic Analysis
The unbiased expected heterozygosity by locus for 
pfhrp2-deleted and non-deleted parasites was calculated 
using GenAlEx version 6.5 and plotted in R [24, 25]. To 
visualize potential relationships between individual para-
sites, we generated a matrix of pairwise genetic distances 
between parasites using GenAlEx for haploid simple-se-
quence repeats, with missing data interpolated by insert-
ing the average genetic distances for each population-level 
pairwise contrast [24, 25]. We then created a neighbor-join-
ing tree using the APE package in R and visualized the tree 
using Cytoscape [26, 27].
To explore genetic differentiation between parasite popula-
tions, we calculated the observed GST for pfhrp2-deleted par-
asites versus controls overall and by province. GST, a measure 
of genetic distance between populations that can incorporate 
multiple genetic markers, was calculated using the formula of 
Nei at each locus before averaging over all loci [28]. We used 
permutation testing to determine the statistical significance 
of observed GST values; population labels (pfhrp2-deletion vs. 
positive control) were permuted 99,999 times and the position 
of the observed value in this ordered list was converted to an 
empirical p-value.
Data Analysis
We made comparisons using Fisher’s exact test for categori-
cal variables, the Wilcoxon rank-sum test for non-normally 
distributed continuous variables, and the t-test for normally 
distributed continuous variables. Statistical analyses were per-
formed using SAS 9.4 (SAS Institute, Cary, NC) and R software.
RESULTS
Prevalence and Geographical Distribution of pfhrp2-Deleted  
P. falciparum
We identified 149 P.  falciparum isolates with a deletion of the 
pfhrp2 gene, representing a country-wide prevalence of 6.4% 
(95% CI 5.1  – 8.0) among the 2,752 children diagnosed with 
P. falciparum infection by real-time PCR and 19.0% of the 783
RDT-/PCR+ parasites tested. Figure  1 and Supplementary
Figure 1 outline the outcome of PCR assays employed to detect
deletions of the pfhrp2 gene and to confirm the presence of
P. falciparum DNA. Of the 149 pfhrp2-deleted P.  falciparum
isolates, only 5 (3.4%) had co-existing complete pfhrp3 dele-
tions (Supplementary Figure 1). We did not identify any pfhrp2
deletions among the 107 RDT+/PCR+ parasites detected in
children from Kinshasa, North Kivu, or South Kivu Provinces.
The characteristics of children diagnosed with P.  falciparum
infection by PCR and the subset with pfhrp2-deleted P.  falci-
parum are described in Table  1. We include previously pub-
lished results of the initial P.  falciparum ldh (pfldh) real-time
PCR for reference.[18, 19] Pfhrp2-deleted parasites had lower 
parasite densities than wild-type parasites (p < .0001), with 
mean pfldh cycle threshold values of 36.1 (standard deviation 
[SD] 3.2) and 32.7 (SD 3.6), respectively. Children infected 
with pfhrp2-deleted P.  falciparum were significantly younger 
than those infected with wild-type parasites (p = .0007) and 
more likely to be microscopy-negative (p < .0001) and afe-
brile (p = .0004). There was no significant difference in gender 
between the groups (p = .92).
Pfhrp2-deleted parasites were present in nearly all provinces 
but were significantly clustered in the provinces surrounding 
the capital Kinshasa in the southwest and Lake Kivu in the 
northeast (Table  1 and Figure  2). They were especially com-
mon in Kinshasa, where they were responsible for more than 
one of every five P.  falciparum infections. A  Bayesian spatial 
cluster analysis supported significant geographical clustering 
of pfhrp2-deleted parasites in Kinshasa Province (posterior 
probability of cluster membership = 0.99) and three provinces 
in the northeast near Lake Kivu (posterior probabilities of 0.69 
in South Kivu, 0.70 in North Kivu, and 0.69 in Ituri Provinces 
[Supplementary Figure 2]). A sensitivity analysis using differ-
ent prior probabilities for no clustering (0.50) and different 
scanning windows (up to 50% of the study population) did not 
change the results meaningfully (Supplementary Figures 3 and 
4, Supplementary Material). The pattern of deletions (i.e. com-
plete deletion of the gene, partial deletion of exon 1, or par-
tial deletion of exon 2) is depicted in Supplementary Figure 5. 
Because spatial clustering suggests the possibility of per-
son-to-person spread and/or expansion of the mutant parasite 
population, we attempted to obtain genetic evidence for spread 
and selective pressures using microsatellite analyses.
Genetic Origins of pfhrp2-Deleted P. falciparum
Failure to amplify microsatellite loci 1.4kb and 2.5kb down-
stream in pfhrp2-deleted parasites suggests that the predomi-
nant gene deletion pattern spans at least several kilobases and 
includes regions downstream from the pfhrp2 gene (Figure 3). 
This pattern of amplification failure was most common 
Figure 1. Study population and PCR results. Abbreviations: PCR, polymerase 
chain reaction; RDT, rapid diagnostic test.
in pfhrp2-deleted parasites from Kinshasa, but it was also 
observed in a subset of parasites from North and South Kivu. 
These findings, in conjunction with the distribution of partial 
versus complete gene deletions (Supplementary Figure 5), sug-
gest that there are multiple deletion genotypes circulating in 
the DRC.
We did not observe clear evidence of a selective sweep 
(Figure  3), although there appeared to be loss of heterozy-
gosity at a single microsatellite locus 15kb downstream from 
the pfhrp2 gene (unbiased expected heterozygosity of 0.66 
among pfhrp2-deleted parasites and 0.93 among controls). 
Amplification failure among pfhrp2-deleted parasites prevented 
similar analyses at the two proximal downstream loci.
Initial analysis of haplotypes using an unrooted neigh-
bor-joining tree revealed three distinct clusters of pfhrp2-de-
leted parasites, one containing primarily isolates from Kinshasa 
Province, another containing a mixture of isolates from North 
and South Kivu, and a third containing a mixture of isolates from 
all three provinces (Figure 4). Because analysis of individual loci 
did not provide sufficient discriminatory power to distinguish 
parasite populations (Supplementary Table 2), we explored the 
genetic relatedness of pfhrp2-deleted parasites and non-deleted 
controls using a permutation test based on the statistic GST. This 
analysis revealed significant genetic differentiation between the 
two populations (GST = .046, p ≤ .00001, Figure 5). Inclusion 
of the parasites’ geographical origins in the analysis confirmed 
significant differentiation between pfhrp2-deleted and non-de-
leted parasites in both Kinshasa (GST = .079, p ≤ .00012) and 
Kivu (GST = .06, p ≤ .0004).
Relationship Between pfhrp2-Deleted Mutants and P. falciparum 
Prevalence
P. falciparum infections are presumed to be more polyclonal in
areas of higher prevalence [29, 30]. Accordingly, coinfections
with a more diverse population of wild-type parasites could
increase the probability of a positive RDT and mask the pres-
ence of pfhrp2-deleted parasites. We observed a decline in the
frequency of presumed monoclonal infections by parasites har-
boring a pfhrp2 deletion at higher parasite prevalence, consistent 
with this hypothesis (Figure 6 and Supplementary Material).
Figure 2. Distribution of pfhrp2-deleted P. falciparum parasites.
DISCUSSION
This is the first nationally representative study to demonstrate 
the presence and estimate the prevalence of malaria caused by 
pfhrp2-deleted P.  falciparum in asymptomatic children. Our 
findings suggest that nearly one of every 15 children with fal-
ciparum malaria in the DRC are infected by a pfhrp2-deleted 
mutant. Because most RDTs employed in the DRC are HRP2-
based, they will fail to detect these parasites.
Several provinces had a markedly higher prevalence of 
pfhrp2-deleted mutants. The high prevalence observed in Kivu 
and Kinshasa is especially concerning because RDTs appear to 
have been introduced in these regions prior to introduction else-
where. HRP2-based RDTs have been deployed in humanitarian 
interventions in Kivu since at least 2005, whereas they were 
deployed in most remaining regions in approximately 2011 [31–
33]. In Kinshasa, HRP2-based RDTs were deployed on a limited 
basis by at least 2009 and their availability increased 10-fold by 
2013 [34]. Geographic and genetic clustering of pfhrp2-deleted 
mutants raises concern for evolutionary selection in the setting 
of selective treatment of RDT-positive P. falciparum parasites.
There are several lines of evidence confirming that our inabil-
ity to detect the pfhrp2 gene was not simply due to insufficient 
DNA, an important consideration in this type of study [35]. The 
presence of amplifiable DNA in pfhrp2-deleted samples was 
confirmed by PCR assays for multiple single-copy genes (pfldh, 
pfhrp3, and/or Pf β-tubulin) and, for a subset, six microsatellite 
loci flanking the pfhrp2 gene. We successfully amplified pfhrp3 
in 96.1% of pfhrp2-deleted P. falciparum isolates with sufficient 
sample remaining for testing and multiple flanking microsat-
ellite loci in all pfhrp2-deleted parasites included in the popu-
lation genetic analysis. For those considering similar analyses, 
useful recommendations for streamlining the process of identi-
fying pfhrp2-deleted P. falciparum are now available [36].
Figure 4. Neighbor joining tree. Unrooted neighbor joining tree depicting the 
relationship between dominant haplotypes of pfhrp2-deleted P. falciparum isolates 
(yellow) and HRP2-positive controls (gray). Shapes indicate the geographical origin 
of each isolate: Kinshasa (circle), North Kivu (triangle), or South Kivu (diamond).
Figure 3. Flanking microsatellites. Analyses revealed frequent failure to amplify flanking microsatellite loci downstream from the pfhrp2 gene and reduced expected 
heterozygosity at a single locus in pfhrp2-deleted parasites overall (panel A) and by province (panel B).
Only a small fraction (3.4%) of pfhrp2-deleted parasites had 
coexisting pfhrp3 deletions, a finding that contrasts with reports 
from South America [36]. Because pfhrp3 produces an antigen 
(HRP3) that shares epitopes with HRP2, pfhrp2-deleted parasites 
with an intact pfhrp3 gene can, in theory, trigger a positive HRP2-
based RDT. This phenomenon may afford select RDTs a “fail-
safe” against pfhrp2-deleted parasites. By examining RDT-/PCR+ 
parasites, it is possible that we may have underestimated the true 
prevalence of pfhrp2-deleted parasites. However, we expect this 
effect to be small given that we did not detect any additional 
pfhrp2-deleted parasites during testing of RDT+/PCR+ parasites 
from Kinshasa, North Kivu, and South Kivu Provinces.
We observed a notable improvement in our ability to amplify 
pfhrp2 exon 1/2 using a lower extension temperature during 
PCR cycling. This finding likely reflects impaired Taq poly-
merase extension of the AT-rich intron at higher tempera-
tures due to DNA melting [21]. Future assays employed to 
detect pfhrp2-deleted parasites, especially those that target the 
AT-rich intron between exons 1 and 2, should be tested at lower 
extension temperatures to avoid unintentional misclassification 
based on false-negative PCR results.
Population genetic analyses of flanking microsatellites con-
firmed that parasites with a pfhrp2 deletion were genetically 
distinct from wild-type parasites in both Kinshasa and Kivu. 
While we did not observe evidence of a selective sweep, the loss 
of heterozygosity observed at a single locus downstream raises 
the possibility of a “soft selective sweep” in the population, with 
multiple genetic origins of the deletion due to multiple break-
points. Soft selective sweeps have been observed in analyses of 
pfmdr1 duplication, implicated in antimalarial drug resistance, 
in Southeast Asia [37]. Additionally, recent analyses of benefi-
cial copy number variation mutations in P. falciparum did not 
reveal the typical long flanking haplotypes required to produce 
“hard” selective sweeps, which are usually observed around 
point mutations [38].
Although we cannot draw definitive conclusions about 
whether selective pressure is responsible for the pfhrp2 deletion, 
the ability to evade detection by a widespread diagnostic test 
Figure 6. Relationship between pfhrp2-deleted mutants and overall P. falciparum prevalence. (A) Scatterplot by province comparing the proportion of P. falci-
parum infections due to pfhrp2-deleted mutants and overall P. falciparum prevalence. Colors correspond to Kinshasa (blue), North Kivu (red), South Kivu (green), and other 
(gray) Provinces. (B) Modeling results showing the predicted decrease in probability of infection with the pfhrp2-deleted strain only, as a function of prevalence in 0–5 year 
olds. The underlying strain frequency is held at a constant frequency in this example. Results are shown for a simple model assuming homogeneous force of infection through-
out the population, and a more complex model allowing for variation in biting rate between individuals (see Supplementary Material).
Figure 5. Permutation testing for GST. Value of observed GST between pfhrp2-deleted and HRP2-positive control P. falciparum populations (black arrow) compared with 
the distribution of GST obtained from 99,999 permutations of population labels. Analysis was carried out for all sites (A), as well as Kinshasa only (B) and Kivu only (North 
and South combined) (C).
would provide significant evolutionary advantages for the P. fal-
ciparum parasite. Clonal selection of pfhrp2-deleted parasites 
could jeopardize recent gains in malaria control, already threat-
ened by the rising tide of resistance to artemisinin-based com-
bination therapies in Southeast Asia and to insecticides [1, 39].
Pfhrp2-deleted parasites may be easier to detect in areas of 
low transmission intensity because polyclonal infections are less 
likely to occur—i.e. co-infection with wild-type parasites could 
trigger a positive RDT and mask the presence of a pfhrp2-de-
leted parasite [36]. The inverse relationship we observed 
between the prevalence of pfhrp2-deleted mutants and overall 
P. falciparum prevalence is consistent with this hypothesis. If
correct, this hypothesis implies that RDT failure due to pfhrp2
deletions will become more common as transmission declines.
There are several limitations to this study. First, our ability to 
explore clinical differences between pfhrp2-deleted and wild-
type P.  falciparum malaria is restricted by limited clinical data. 
Ongoing studies of symptomatic malaria in the DRC may provide 
valuable insights into the clinical manifestations of infection with 
pfhrp2-deleted parasites. In the present study, however, subjects 
were enrolled in a large, country-wide survey and not selected 
based on symptoms of malaria. As a result, we cannot draw con-
clusions about the relative virulence of pfhrp2-deleted parasites. 
While the lower parasite densities by real-time PCR and the lower 
proportion of microscopy-positivity and fever among pfhrp2-de-
leted P. falciparum cases (Table 1) may simply reflect our ability to 
detect deletions in less complex infections as noted above, these 
findings also raise the possibility that there may be a fitness cost 
to the parasite. Our finding that children infected with pfhrp2-de-
leted parasites were younger than those infected with wild-type 
parasites could reflect the immature immune system of younger 
children, who may mount a weaker response to these less fit par-
asites. The function of pfhrp2 is not well understood, but detoxi-
fication of heme and other possibilities have been suggested [40]. 
While parasite clones containing the pfhrp3 gene were favored 
over pfhrp3-deleted clones in a genetic cross, the same has not 
been demonstrated for pfhrp2 in vitro [41].
Second, our study was restricted to the DRC. While this may 
raise questions about generalizability, the DRC is a large and 
geographically diverse country that borders nine other coun-
tries in East, West, and Southern Africa, suggesting that our 
findings have relevance throughout the region.
Independent of concerns about evolutionary selection, our 
findings represent the first report of geographical clustering of 
pfhrp2-deleted P. falciparum parasites in Africa, where HRP2-
based RDT use is most common [1]. Malaria is widespread in 
the DRC; at least 34.8 percent of the children in this cohort were 
infected with P. falciparum parasites. These and other infected 
African children bear the brunt of malaria’s heavy toll. Rapid 
and accurate diagnosis of P.  falciparum infection, especially 
among clinically ill patients presenting for evaluation and 
treatment, is essential for curbing its effects. RDTs that detect 
antigens other than HRP2 such as lactate dehydrogenase (LDH) 
and aldolase are commercially available, but they are not widely 
utilized in sub-Saharan Africa due to concerns about heat sta-
bility and inferior P.  falciparum sensitivity, higher costs, and 
limited global availability compared to HRP2-based RDTs [42, 
43]. Multilateral donors currently invest hundreds of millions 
of dollars in the procurement and distribution of HRP2-based 
RDTs. Our findings underscore the need for surveillance of 
pfhrp2-deleted mutants and suggest that alternative diagnostics 
need to be considered in areas where these deletions are com-
mon. Use of RDTs that detect multiple antigens (e.g. HRP2 and 
LDH) or novel P. falciparum-specific antigens may be required.
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